Implementing online evidence-based care pathways: A mixed-methods study across primary and secondary care by Akehurst, Joy et al.
Akehurst,   Joy,   Sattar,   Zeibeda,   Gordon,   Isabel   and   Ling,   Jonathan   (2018) 
Implementing   online   evidence­based   care   pathways:  A  mixed­methods   study 
across primary and secondary care. BMJ Open. 
Downloaded from: http://sure.sunderland.ac.uk/id/eprint/10469/
Usage guidelines
Please   refer   to   the  usage guidelines  at  http://sure.sunderland.ac.uk/policies.html  or  alternatively 
contact sure@sunderland.ac.uk.
1Akehurst J, et al. BMJ Open 2018;8:e022991. doi:10.1136/bmjopen-2018-022991
Open access 
Implementing online evidence-based 
care pathways: A mixed-methods study 
across primary and secondary care
Joy Akehurst,1 Zeibeda Sattar,2 Isabel Gordon,1 Jonathan Ling1
To cite: Akehurst J, Sattar Z, 
Gordon I, et al.  Implementing 
online evidence-based care 
pathways: A mixed-methods 
study across primary and 
secondary care. BMJ Open 
2018;8:e022991. doi:10.1136/
bmjopen-2018-022991
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
022991).
Received 18 March 2018
Revised 6 October 2018
Accepted 2 November 2018
1University of Sunderland, 
Sunderland, UK
2Northumbria University, 
Newcastle upon Tyne, UK
Correspondence to
Professor Jonathan Ling;  
 jonathan. ling@ sunderland. ac. uk
Research
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Aim To understand what contextual influences, 
mechanisms and outcomes affect the implementation and 
use of localised, online care pathways (HealthPathways) in 
primary and secondary care.
Design and procedure Mixed-measures design. 
Quantitative data included number of page views and 
conditions viewed. Qualitative data from semistructured 
interviews and focus groups were gathered over a 
6-month period, and analysed using NVivo software.
setting The first HealthPathways UK site, South Tyneside, 
England.
Participants General practitioners, nurses, practice 
managers, hospital consultants and system leaders 
(managers, commissioners) (n=76).
results Use of the pathways significantly increased 
over time. Themes were developed showing how online 
care pathways were used—leadership, pre-existing 
networks and relationships; development of systems 
and processes for care pathways, the use of online care 
pathways to support decision-making and referral, and 
perceived availability of resources. Inter-related themes 
were arranged into configurations consisting of contextual 
influences, mechanisms and outcomes. Recommendations 
were made for future implementations, such as improved 
data collection processes to understand how and why 
there was variance in the use of pathways.
Conclusions This study was early in the implementation 
process; however, emerging themes will facilitate the 
future implementation and use of online care pathways. 
Recommendations are made for further research to 
include other health and social care users and patients to 
inform future developments.
IntroDuCtIon 
The National Health Service (NHS) Five Year 
Forward View1 emphasises integration and 
collaboration across a whole system to make 
best use of resources and improve the patient 
care experience. Workforce development 
and technology have been identified as two 
factors which facilitate integrated working, 
reduce variability in care and improve effi-
ciency.2–7 Online care pathways enable 
rapid access to evidence-based resources for 
professionals to support decision-making, 
treatment, care planning and referral, for 
elective and non-elective care.8 Clinical path-
ways can also improve communication, team-
work and care planning in multidisciplinary 
teams, which in turn helps coordination of 
care across organisations.9 Evidence-based 
information used at the point of care has 
also been reported to mitigate risk, be effec-
tive in improving patient care outcomes and 
reduce cognitive overload which can lead 
to medical errors.10 11 The concept of ‘task 
transfer’ changing roles and responsibilities 
is also evident within policy and literature on 
care pathways, for example, from medical to 
nursing and allied health professionals.12 13 
Canterbury District Health Board in New 
Zealand is internationally recognised for 
transforming its health system through inte-
gration and collaboration, reducing acute 
hospital admissions, treating more patients 
outside of hospital, with strong staff engage-
ment across the health and social care 
system.14 15 Part of this whole system approach 
is HealthPathways,16 an online repository of 
>550 evidence-based care pathways with the 
aim of providing the right care, in the right 
place at the right time, to reduce variability 
and increase efficiency. HealthPathways 
strengths and limitations of this study
 ► This is the first UK study of the implementa-
tion and use of localised, online care pathways 
(HealthPathways) across health and social care.
 ► The study was time-limited, with limited quantitative 
data available for analysis.
 ► Data relating to referrals made following use of 
HealthPathways would have enabled a deeper un-
derstanding of variance in use of agreed care path-
ways. These data could have also been used as part 
of the interviews and focus groups, to draw out fur-
ther learning.
 ► The focus was mainly on general practitioner users 
and system leaders.
 ► Future research should focus on a wider range of 
HealthPathways users including nurses, allied health 
professionals and patients.
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provides a combination of clinical guidelines, local 
process information (for referrals and diagnostics and 
associated clinical responsibilities), service directory 
information and patient information. For example, a 
primary care clinician can access a pathway for cogni-
tive impairment, which includes which tests/assessments 
should be conducted in a primary care setting (agreed 
between primary and secondary care clinicians), differen-
tial diagnoses, when and how to refer to a local specialist, 
what local services there are to support the patient and 
their family, and information about the condition for 
patients. HealthPathways has been implemented in 33 
sites in New Zealand and Australia, in largely mixed 
private and publicly funded health and social care econo-
mies, covering >25 million people.17 18
South Tyneside in the northeast of England is an 
NHS Integrated Care Pioneer19 and the first UK site to 
implement HealthPathways. HealthPathways went live in 
August 2016 with 50 care pathways accessed via a weblink.
The aim of the study was to understand what contextual 
influences, mechanisms and outcomes affect the imple-
mentation and use of localised, online care pathways 
(HealthPathways) across primary and secondary care for 
this national pilot site.
MethoDs
The study methodology draws on the realist approach 
to evaluation,20 providing an explanatory analysis aimed 
at showing what works for whom, under what circum-
stances, in what respects and how in order to provide an 
in-depth understanding of an intervention and how it can 
be made to work most effectively. In this paper, we focus 
on examining the relationship between the context in 
which the HealthPathways system is applied, the mech-
anisms by which it works and the outcomes which are 
produced.21 This approach is useful as a pragmatic way 
of understanding the contextual complexity within which 
interventions can take place and influences over how they 
work, such as with HealthPathways where there may be 
multiple external variables or where there is an evolving 
intervention.20 22 23
Data gathered included HealthPathways usage data, 
interview and focus group data. Semistructured topic 
guides developed for one-to-one interviews and focus 
groups included broad issues identified through docu-
mentary analysis and in current evidence on clinical 
pathway systems and HealthPathways. Focus group and 
interview data were collected to provide rich data across 
disciplines and team members.
Sets of themes generated via analysis using NVivo soft-
ware were arranged as configurations under the head-
ings of context, mechanisms and outcomes (see table 1). 
During manual analysis, themes found to be inter-related 
both within these headings and across each configuration 
were included.
sampling and recruitment
Ten general practitioner (GP) practices in South Tyne-
side were purposively sampled and invited to participate 
in interviews and focus groups. Participants were selected 
based on variables such as geographic location, size of 
practice, years of experience as GPs and whether they 
were currently users of HealthPathways, to ensure a wide 
range of views. Four of the practices were unable to partic-
ipate within the time frame of the study due to external 
pressures (planned Care Quality Commission inspection, 
practice mergers). Hospital consultants were also invited 
to participate. Participants (n=76) included GPs, district 
nurses, practice nurses, practice managers, healthcare 
assistants and system leaders. System leaders (clinical and 
non-clinical) either had roles in the strategic or opera-
tional development of HealthPathways, in individual 
pathways as subject matter experts or were clinical editors 
(two GPs who worked part-time to support the writing of 
pathways). Three of the system leaders had clinical and 
management responsibilities (hospital consultants). One 
system leader was from a social care background. Four 
focus groups of GP teams were held with a total of 45 
participants. 
Data collection
Quantitative
Data were generated from the HealthPathways system 
using Google Analytics. Data included number of 
Table 1 Themes for each of the configuration
Configuration Context Mechanism Outcome
  1 Strategy
Ethos
Leadership Uptake
  2 Pre-existing strong networks and 
relationships
Canterbury District Health 
Board input
First impressions from introduction phase
  3 Systems for development of 
HealthPathways and individual 
pathways
Development process
Training
Practical usage
Feedback
  4 Decision-making and referrals HealthPathways for referrals
Two-way communication
Task transfer
Compliance with pathways
Specific pathway outcomes—patient 
stories
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HealthPathways sessions and page views, number of users 
and use of specific pathways. Data were collected between 
19 August 2016 and May 2017.
Qualitative
Data from 15 semistructured interviews with system 
leaders and GPs as well as 4 focus groups (n=45) of GP 
practice team members were conducted. The interviews 
and focus groups took place in general practice meeting 
rooms, or sites most suitable for participants and lasted 
between 30 and 90 min. Qualitative data were digitally 
recorded and transcribed verbatim prior to analysis by 
the research team. Notes from observations of two project 
meetings (n=8) between system leaders, commissioners 
and the research team were taken to support analysis.
Data analysis
Quantitative
Data on use of HealthPathways were collated as a means 
of understanding the level of engagement. Number of 
sessions, page views and users were all collected monthly 
and analysed by correlation.
Qualitative
Thematic analysis was carried out using the qualitative 
research software package Nvivo; manual analysis was 
used to refine the initial findings. Context, mechanism 
and outcome configurations were developed from the 
themes emerging from the data. To improve validity, 
coding and interpretations were discussed by members of 
the research team (JA, ZS, IG) at regular meetings during 
analysis.
report writing
We used the SQUIRE checklist when writing our report.24
Patient and public involvement
Patients were not involved in developing this initial study 
as the focus was on clinician use of online health and 
social care pathways.
results
Quantitative data
There were 130 GPs in South Tyneside who were given 
access to HealthPathways via a weblink for each practice. 
Other users in the practice also potentially had access.
In total, there were 7544 sessions on HealthPathways 
and 37 186 page views in the study period. The number of 
sessions increased over this period from 477 to 1009, and 
the number of page views from 3309 to 4766 (figures 1 
and 2). There was a steady increase in use, suggesting the 
pathways were being accessed more regularly by prac-
titioners. Over time, there were significant increases in 
numbers of both sessions (r=0.843, n=10, p=0.02) and 
users (r=0.794, n=10, p=0.006), with a trend towards there 
being an increase in page views (r=0.627, n=10, p=0.052).
In May 2017, 252 users had logged onto HealthPath-
ways (figure 3). As there are 130 GPs in South Tyneside, 
there were potential multiple logins or other users than 
GPs. At the time of writing, the ability to determine who 
these were was unavailable.
Qualitative data
Themes that illustrate how HealthPathways might be 
implemented and used over the long term were identi-
fied. These themes are summarised as configurations in 
table 1 within the framework of context, mechanisms and 
outcomes set out in the realistic evaluation model.22
Figure 1 Number of sessions on South Tyneside HealthPathways from 16 August 2016 to 31 May 2017. A session is defined 
as a login to the online care pathway repository.
Figure 2 Number of page views of South Tyneside HealthPathways from 16 August 2016 to 31 May 2017.
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Themes reported under ‘Context’ refer to the organ-
isational structure, systems and ethos within which the 
HealthPathways system was embedded. Themes under 
the heading ‘Mechanism’ refer to processes by which 
the HealthPathways system was used and developed by 
participants. ‘Outcome’ themes refer to how participants 
perceived the HealthPathways system to have influenced 
particular contexts.
The configurations derived from thematic analysis of 
the data are described below.
Configuration 1: strategy–leadership–uptake
This configuration focuses on the introduction phase 
and brings together the contextual theme of strategy, the 
mechanism theme of leadership and the outcome theme 
of uptake. These closely interlinked themes encompass 
how HealthPathways was set up within the localised user 
community.
The strategy for HealthPathways focused on what 
implementing it meant for the health and social care 
system and what motivated people to engage with it. 
Many system leaders were aware that HealthPathways was 
part of a system-wide transformation programme and 
were optimistic that it would help reduce pressure due to 
lack of resources in the locality. One strategy for imple-
mentation was a launch event which was well-attended 
(n=180) that aimed to engage clinical users with the idea 
of HealthPathways and encourage them to use it.
I think the launch that we did … I think, really did 
go a long way to selling it to people. (System leader, 
I1, p. 5)
A fundamental part of the HealthPathways strategy was 
its underpinning ethos. The way this was presented to 
users was a key leadership tool both at the launch and in 
ongoing project meetings and clinical forums. The ethos 
was focused on working together towards a common goal 
with an absolute commitment to partnership across all 
professional groups involved in the development, use and 
maintenance of the HealthPathways system.
We’re talking about a way of working, we’re talking 
about empowering clinicians and saying just do 
what’s right—they do that. (I2, p. 5)
The optimism expressed by system leaders that the 
ethos of HealthPathways would be integrated into the 
working system did not always come across from those 
using the system, who were faced with practical chal-
lenges such as time pressures and using the system while 
multitasking. The challenges of getting people on board 
with this change in thinking were also acknowledged by 
the Canterbury team leader:
It’s getting your people engaged in the change that 
will make a difference over time. That’s the experi-
ence of Canterbury. It comes back to that cultural 
underpinning stuff again. (Canterbury team leader, 
I3, p. 13)
An early introduction to this ethos as an integral part of 
the HealthPathways working culture was seen by system 
leaders to reinforce users’ faith that HealthPathways 
would work. Overall, system leaders including GPs and 
hospital consultants perceived themselves to be ‘singing 
from the same hymn sheet’ (system leader, I6, p. 12) in 
advocating the philosophy, values and open work ethic of 
HealthPathways.
So there was a sense of real commonality, even 
though, very clearly, they’re halfway round the world, 
but there was an obvious synergy in what they were 
doing and had done over the previous ten years and 
what we were trying to do in the borough. (System 
leader, I4, p. 2)
Leadership and exposure to leaders appears to have 
had a positive and motivational effect on potential users. 
Leaders included the Canterbury Team, system leaders, 
clinical editors and subject matter experts in primary and 
secondary care. Several participants commented on the 
importance of having a local champion. System leaders 
also recognised that gaining clinicians’ interest and 
understanding of HealthPathways and the ethos under-
lying it could be a challenge, but integral to its successful 
implementation.
… persuasion of the secondary care community that 
they should give their time to come and be involved 
in these [launch/training events], is quite a signifi-
cant ask … they totally need to get this. That is a chal-
lenge. (System leader, I4, p. 14)
Some comments suggested a need for careful manage-
ment of users’ expectations about HealthPathways during 
the set-up phase such as how it could be used, time commit-
ment and how HealthPathways would benefit users.
Figure 3 Number of users from August 2016 to May 2017 for South Tyneside HealthPathways.
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R2: The CCG had a big roll-out event that we were all 
invited to come to.
R1: I think it was a bit over-sold. Because it 
[HealthPathways] doesn’t give us all the answers that 
we want … (GP, I15, p. 4)
The clinical editors and subject matter experts felt they 
were developing a key leadership role in service develop-
ment which they had not anticipated and were anxious 
about:
We’ve been asked to look at when we're writing a 
pathway, … are there areas where we can see that 
we could try and make a change? I think sometimes 
that's felt a little bit daunting. (Clinical editor, l9, 
p. 4)
The uptake of HealthPathways appeared to be influ-
enced by their initial perceptions of the system gained 
from the introduction phase. They commented on the 
launch event, training provided, education forums and 
first experiences of using the system and seemed to value 
the training, strong leadership and fast responses when 
providing feedback. They recognised that their views 
were formed on the basis of HealthPathways being newly 
introduced and that gaining trust in the system may take 
time.
I fired off an email and within 24 hours the editors 
had looked at it, dealt with it, said thank you, and it 
was updated and it was working beautifully. So they 
are incredibly responsive if people are willing to 
[try]. (GP, I7, p. 7)
Participants who did not attend the launch or who had 
not met those who had successfully implemented Health-
Pathways appeared less enthusiastic about system trans-
formation opportunities and benefits for patients. For 
some clinicians it was gaining insight from peers which 
was most persuasive. For example, practices where GPs 
were developing pathways their GP colleagues seemed to 
be more engaged with HealthPathways:
We’ve had quite a lot of information leading up to 
Health Pathways, when we’ve been to talk to some of 
the CCG. […] One of the GPs in the practice works 
at the CCG as well. So, we’ve had quite a lot of infor-
mation … (GP, l4, p. 1)
Practical suggestions were made to both improve and 
ensure the uptake of HealthPathways i, for example, 
linking HealthPathways to the patient health record or 
the referral system, both of which would save users time. 
System leaders acknowledged clinicians’ lack of time in 
their strategy to ‘only push where the open door is’ (I2b, 
p. 6). Time delays in developing and agreeing pathways 
with hospital medical staff were reported by GPs involved 
as subject matter experts as having the potential to affect 
uptake.
Configuration 2: pre-existing strong networks and relationships— 
- Canterbury District Health Board input—first impressions
This configuration describes how the presence of existing 
working relationships (context) set the scene for the 
involvement of the Canterbury team in launching Health-
Pathways and training people to lead and use the system 
(mechanisms). Clinicians’ first impressions of Health-
Pathways from the introductory phase were outcomes.
Participants across groups described the pilot area as 
having particularly strong networks that were in place 
before HealthPathways was introduced. These influenced 
overall impressions of HealthPathways from the outset. 
They recognised this context as unusual and felt this was a 
key factor in the effective implementation of HealthPath-
ways locally. The Canterbury team were struck by the level 
of formal and informal dialogue between stakeholders:
.… they’d already worked very hard to develop a lot 
of the relationships between the key players, which 
was the prime reason that we came here. And they 
had some leaders in place who were motivated to 
[promote] change. (Canterbury system leader I3)
There was also optimism about the role of educa-
tional forums where relationships had already devel-
oped between clinicians; these were felt to be potentially 
useful for giving feedback on the development, use and 
outcomes of pathways.
I became much more enthusiastic about Health 
Pathways after going to a care of the elderly meeting 
… that certainly contributed to developing a path-
way …. which is possibly more important than the 
actual guideline. (GP, I7, p. 2)
Involvement of the Canterbury team was seen as funda-
mental in helping establish use of the HealthPathways 
system and reinforcing what worked for them in a new 
locality. For example, system leaders in South Tyneside 
commented on how the Canterbury Team helped realise 
their existing networks and relationships:
The major thing that, I think, we took from 
Canterbury, was really about the partnership ele-
ment. So, this was not about organisational barriers 
or boundaries, it was really about trying to open up 
much more and be part of the system and work a sys-
tem together … (System leader, I4)
Participants’ first impressions of HealthPathways 
revealed differences in opinion between and within 
groups about to start using the system. Those from both 
clinical and non-clinical settings reported system fatigue 
and practitioners’ lack of time being the context for its 
introduction.
I’m not asking it to be discussed every month [at prac-
tice meetings] just a little reminder to keep letting 
people know it is there. Otherwise it will just dwindle 
away like everything else. (GP, I10, p. 5)
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Clinicians’ reasons to use HealthPathways varied, for 
example, some hospital consultants saw the trade-off 
between investing time and the resulting information 
available as beneficial, some GPs saw it as an information 
resource and others expressed caution about promoting 
the use of HealthPathways to reduce secondary care 
demand.
It’s an accessible way of me getting the answers that I 
want that are going to help me with a particular pa-
tient I have sat in front of me. And that’s not always 
about reducing demand on secondary care … (GP, 
I12, p. 2)
However, others were unsure of the impact of Health-
Pathways on their practice at this early stage:
I don't think it's made a massive difference to my 
referral patterns. But that might be if I used it a bit 
more, it could. I don't know— [Name] is a bit more of 
an enthusiast. But it's only just started. (GP, I7, p. 4)
In contrast, both clinical and non-clinical system 
leaders seemed more confident in the usage of Health-
Pathways and felt HealthPathways was a way to improve 
efficiency by preventing illnesses progressing by speeding 
up referrals to the correct place, thereby saving money 
rather than cutting back on services.
… you can see that they [GPs] are using it. They ap-
preciate that the information is in one central reposi-
tory and they are referring when needing to refer and 
doing what actually should be done in primary care. 
(System leader/hospital consultant, I8, p. 2)
There were some tensions between GPs and hospital 
consultants in their perceptions of how HealthPathways 
was used and the benefits it offered them which may have 
an impact on long term use. There was concern about 
creating a ‘them and us culture’ (GP, I17, p. 14) with 
the patient in the middle, when the intended seamless-
ness between primary and secondary care did not work. 
Another concern was whether input into the develop-
ment of a pathway was required from both primary and 
secondary care, or from clinicians with different clinical 
backgrounds:
The pathway sits, sort of, between myself and with 
[Name], who’s one of our elderly care consultants. 
So, it had to be done jointly, and again there were 
complications in terms of input from my side, from 
her side, and then pulling all that together and where 
the pathway sits neatly in speciality, perhaps, it’s a bit 
more straightforward. (System leader, 19)
Some secondary care participants expressed concerns 
that the online care pathways would mean a potential 
shift of resources to primary care from the hospital, 
despite the hospital having a contract, which was not 
at that time funded by activity levels. Some GPs wanted 
to use the care pathways repository as a tool to demon-
strate their continued professional development, as some 
clinical guidelines systems can; it was thought this may 
encourage more use and promote GPs’ engagement with 
HealthPathways:
The reason that I know other doctors like [another 
online system] is because it logs that you’ve been 
in. So, at any stage you can say ‘Give me a history of 
the things that I’ve looked up.’ And it will give you 
[that] … So that is useful for recording of your con-
tinual professional development … (GP, 12)
Other GPs saw HealthPathways as a directory of services 
or clinical resource rather than a local team approach to 
developing referral pathways. There were also GPs who 
saw it as a tool to support effective and efficient deci-
sion-making, to make better use of resources in the health 
and social care system, and to improve patient care. When 
clinicians were asked if HealthPathways had improved 
their relationships with patients, only a small number of 
users had engaged in any discussion about care pathways 
with a patient; however, some saw the potential:
If we genuinely believe that shared decision-making 
and people being involved in their own care, enables 
and empowers them and increases satisfaction, com-
pliance, then me being able to go through a pathway 
with someone, I think would be helpful … (GP, I7)
While clinicians’ views were mixed there was a common 
element of uncertainty that HealthPathways could be a 
sustainable new approach to delivering care at this stage 
of its development.
Configuration 3: systems for development of HealthPathways and 
individual pathways—development process, training, practical use, 
pathways—feedback
This configuration focusses on the system factors such 
as the way pathways were set out, developed and used by 
participants. The context themes are systems for devel-
opment of HealthPathways and individual pathways, the 
mechanism themes are the development processes and 
practical usage of the pathways and the outputs are feed-
back about pathways.
The systems for development consisted of HealthPath-
ways and individual pathways. Fifty pathways were priori-
tised for initial development based on existing Canterbury 
pathways which could be localised, or which were ‘quick 
wins’ for the system as they did not need localisation, and 
which HealthPathways users identified would be most 
useful from the onset (table 2). Getting the first 50 path-
ways ready for the launch proved challenging for clinical 
editors due to poor planning, lack of information about 
how to do it and a lack of time and staff.
I knew I shouldn’t have been up at two in the morn-
ing doing it … we were just told to get out and go 
and do it … Because we weren’t told, right, these are 
the steps, this is the very detailed process … And it 
just caused delay and challenge. (System leader, I2, 
pp. 13–14)
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There were different approaches to the development 
process for pathways. GPs had mixed views on the process 
of inputting information and getting feedback, some 
found it easy and underlined the importance of a part-
nership approach to developing the system locally; others 
found the differences in medical terminology or time 
delay of working with editors in New Zealand frustrating.
The problem is, currently they're not all localised to 
[the local area]. And that can be very frustrating, to 
go in and find that you've got this problem and the 
way to manage it is to refer it to Canterbury Health 
Board. (GP, I7, p. 3)
Some subject matter experts (consultants and GPs) 
discussed the proposed content via email rather than 
planned subject matter group meetings; however, this 
approach was seen as being less productive and taking 
longer than face-to-face discussion. Using existing clin-
ical education meetings was suggested as a better place to 
discuss and agree care pathways, and was felt would also 
improve integrated working across the system.
It was important to users that their views were listened to 
during the development of pathways. HealthPathways has 
a user feedback system called DOT which enables users 
to log queries or suggested amendments. Users reported 
that they were more likely to engage with HealthPathways 
if they received prompt and positive feedback, when they 
logged a query, as this reinforced their clinical expertise 
seeing their own impact on the system was also a factor 
that motivated them.
… with the blood pressure targets for diabetes …. 
they changed them within 24 hours, saying thanks for 
identifying it, and letting us know what the real [cor-
rect] ones are. We’ve changed it. And it does make 
you buy in, that sort of thing. (GP, I7, p. 7)
Challenges during the development stage of Health-
Pathways included a lack of clinical time to develop, 
agree and use HealthPathways. This was particularly 
challenging for clinical editors who reported that they 
needed more time than planned to set up the initial 
pathways required for the launch. This was because their 
role increasingly had a service development function to 
ensure services were configured in line with the evidence 
base in HealthPathways. This affected timely delivery of 
new pathways and meant additional costs for others in 
the system.
The bottom line is things that would facilitate the use 
of Health Pathways, would be having all the health 
pathways localised at the time of going live. I appreci-
ate there's a financial constraint to doing that … (GP, 
I7, p. 3)
At this early stage, it was unclear how these costs might 
be captured or analysed to be able to demonstrate future 
return on investment. Other clinicians also felt they did 
not receive additional time or financial resources to 
contribute to the development of pathways:
In terms of practical usage, clinicians’ motivation 
seemed to be influenced by the way pathways were set up 
and how they could be accessed.
One of the things that I'm not keen on with the path-
ways, is there are … There are quite a lot of ifs, buts 
and therefores. So you can't follow one through with 
the patient because it is designed for a medic. And 
you can't pick one up that you've not used before 
mid-consultation, because there isn't a natural flow 
to them. There's almost too much information. (GP 
focus group, I7, p. 5)
Training in the use of HealthPathways was made avail-
able for all GP practices, but many felt the system was 
intuitive and easy to use without training. Some of these 
GPs reported using HealthPathways as a resource direc-
tory rather than being involved with the development of 
pathways. Non-clinical system leaders who were not used 
to NHS terminology found this aspect of using Health-
Pathways took time to learn.
Table 2 The 10 most frequently visited pathways in South Tyneside (localised and non-localised), May 2017
Localised pathways Page views Non-localised pathways Page views
Chronic obstructive pulmonary disease 428 End of life 105
Heart failure 406 Hyperlipidaemia 74
2-week wait suspected cancer referrals 350 Differentiating asthma from chronic obstructive 
pulmonary disease
58
Atrial fibrillation 321 Insulin—starting and ongoing management 56
Integrated care teams 306 Type 2 diabetes—newly diagnosed 53
Deep vein thrombosis 250 Abnormal liver function tests 52
Non-acute cardiology 214 Advanced care planning 52
Chronic kidney disease in adults 213 Cardiovascular risk assessment 49
Diabetes continuing care 201 Spirometry interpretation 45
Diabetes diagnosis 200 Urinary tract infection in adults 45
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If you’re from that kind of industry and you already 
know the terminology and things like that, that’s half 
the battle. (System leader, I1, p. 4)
The use of localised pathways was greater and related 
to the most common conditions encountered. Some GPs 
reported however that if a condition was commonly occur-
ring, they would be less likely to view the pathway, as they 
felt they knew what the correct pathway was. There were 
mixed views about using the non-localised, New Zealand, 
pathways. Some felt this was a ‘trust’ issue, that is, whether 
the clinical evidence base would be the same in the UK. 
The fact that some pathways were not localised, accurate 
(in terms of UK practice) or complete was perceived as 
a potential barrier to using the system to its full capacity:
I mean, of course there are lots which are not rele-
vant to us, because it's the New Zealand stuff. Which, 
again, are referred to for the clinical information, but 
not for the referrals and stuff like that … (GP,  I10, 
p. 4)
Others however reported the clinical content of path-
ways which were already developed was as good as, if not 
better than, others developed elsewhere in the UK.
In terms of practical use, HealthPathways was not 
currently integrated into existing patient health and social 
care record systems. This meant users needed to access 
HealthPathways via an additional screen. This switching 
between screens reduced use of HealthPathways. Using 
HealthPathways was also felt to be more difficult if a 
patient was present or when consulting with patients with 
multiple health conditions.
It was a patient who had a number of different health 
conditions. So, one of their health problems meant 
that the straightforward Health Pathways pathway 
would have been inappropriate in their case … (GP, 
I14, p. 5)
At the time of the study, the design of the HealthPath-
ways system was such that data about individual use were 
not available to system leaders; these would have been 
useful to understand patterns of use, and to identify areas 
for further development both in terms of pathways and 
training for users.
Configuration 4: decision-making and referrals—two-way 
communication, task transfer, compliance—specific pathway 
outcomes
This configuration focuses on the use of HealthPathways 
in clinical practice, where context themes were deci-
sion-making and referrals, mechanisms were task transfer 
and two-way communication and outcomes were compli-
ance with pathways or specific outcomes.
A key objective of HealthPathways is to support deci-
sion-making and referral to enable more care to be 
delivered in primary care, community care and patients’ 
homes, and to make best use of resources across the 
system. At the time of data collection, the HealthPathways 
system was still relatively new, and users reported they 
still conformed to their standard decision-making about 
referral. However, users reported they used HealthPath-
ways to check whether the pathway had changed or to 
confirm their knowledge (eg, if they were newly qualified 
or new to the area). Secondary care clinicians, however, 
reported there was not always compliance with pathways 
as they were still receiving referrals despite the pathway 
stipulating referral was inappropriate:
I get the feeling that not all of them are using it. I 
think there are certain conditions that I deal with, 
where if you follow the pathways it’s all there. But 
we’re still getting referrals for some of these cases 
where …, if you follow the pathways, you wouldn’t re-
fer … (System leader, 19)
In addition, the challenges of complying with newly 
agreed pathways were also articulated by a secondary care 
clinician:
I was discharging a patient—very stable, on insulin, 
kidney disease stable—who’d I’d looked after for 12 
years. And I made it clear, you know, ‘discharging you 
back to your GP, but you’ve got a safety net’ etc. … I 
think that [HealthPathways] really is the thing which 
has helped me to do that. And it can be difficult …. 
because you do build your relationship with patients. 
But ultimately, if your clinics are overbooked, are you 
really doing a service? (System leader, I8)
Built into HealthPathways care pathways is the concept 
of ‘task transfer’ from hospital consultants to GPs as 
part of the vision for more care outside of hospital. An 
emerging theme was of task transfer from GPs to nurse 
practitioners and district nurses. The small number of 
nurses in focus groups who had used HealthPathways felt 
they would engage more if HealthPathways could provide 
more clarity about care pathways for patients who were 
discharged from hospital care, as well as for referral in:
In principle, the system is a one-way system. So, it’s 
[HealthPathways] designed to help secondary care by 
us following pathways that they set out for us to follow 
to send the patient in. Perhaps one of the improve-
ments would be if primary care wrote the pathway for 
secondary care to send people back out. (Nurse prac-
titioner, 17)
The importance of two-way communication, task 
transfer and the role of HealthPathways to prevent a 
‘them and us’ culture was a common theme:
I appreciate the volume of work that they [hospi-
tal consultants] do, but I don’t know exactly every-
thing that they do. … if this is truly about integrated 
care—if this is truly about making things better for 
everyone within the NHS, then actually it’s not work-
ing. Because if it’s creating a them-and-us culture … 
That’s no interface at all … (GP, 17)
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Quantitative data on specific pathway outcomes were 
unavailable as the system was not yet sufficiently devel-
oped to be able to do this; however, there were several 
comments from HealthPathways users about when a 
pathway had supported the right care for a patient and 
suggesting there could be positive outcomes for the 
patient.
I’d not seen [the patient] for a very long time … and 
gave them up to date information about that pathway 
and what to prescribe so it was useful. (GP, I14, p. 3)
DIsCussIon
This study is the first to examine the implementation 
of HealthPathways in the UK and was conducted at the 
national pilot site. The study started when HealthPath-
ways had only been operational for 4 months and yet we 
found there was an increasing number of HealthPathways 
users and a number of useful themes from the qualitative 
data which will support other implementations of online 
care pathways. HealthPathways had been in place for 11 
months when the study concluded, so only initial recom-
mendations on improving uptake were suggested. Imple-
menting change, particularly at scale, often require time 
and targeted efforts, a finding which has been reflected 
in other studies.6 25
The four configurations were developed in line with a 
realist approach to explore practical ways of supporting 
future implementations of online care pathways across 
health and social care. These configurations provide 
evidence of the strong commitment of system leaders 
(clinical and non-clinical) to the strategy of HealthPath-
ways implementation. Many clinical stakeholders were 
supportive of the implementation because they believed 
it helped decision-making and referrals. Leadership 
and well-developed pre-existing strong relationships 
across the health and social care economy were viewed 
as important for the sustainability of online care path-
ways and reflect findings from other sites outside the 
UK.26 27 Improved communication through more face-to-
face contact in multidisciplinary education forums would 
support professional and organisational relationships 
and enhance engagement with HealthPathways. It would 
also be a clear pathway for referrals, with the potential 
to reduce tensions between primary and secondary care 
during a time of whole system change.28 Education and 
clinical engagement and collaboration has a prominent 
focus in NHS policy,29 with varying views on whether inte-
grated care pathways are enablers to collaboration or 
vice versa.26 30 31 Our work reflects the importance of clin-
ical engagement and feedback in pathway development 
observed elsewhere.32 33
We used mixed methods to gain insight into the imple-
mentation of HealthPathways within this complex envi-
ronment. The challenges of interpretation of context, 
mechanisms and outcomes configurations are discussed 
in the literature, particularly as realistic approaches are 
increasingly being used in health services implementa-
tion studies.23 34–36 The decision, for example, of whether 
‘leadership’ is a context, mechanism or outcome was 
explored with a purposive sample of HealthPathways 
users and non-users as well as clinical and non-clinical 
participants.
This study therefore focused not only on user percep-
tions of the implementation process but on the systems 
for development of HealthPathways and whether the 
pathways were being used. We found use of HealthPath-
ways and clinicians’ engagement with it was increasing. 
In particular, having local, complete pathways in a single 
repository motivated GPs to use the system. However, GPs 
and consultants who were acting as subject matter experts 
expressed concerns about the process of developing path-
ways in terms of consistency and speed. This meant that 
parts of HealthPathways were considered incomplete 
and therefore perceived to be inaccurate which may 
have influenced motivations to use and contribute to 
HealthPathways.
In HealthPathways sites outside the UK, additional facil-
itators and GP liaison officers work with GPs and clini-
cians16 to support completion of pathways more rapidly. 
Analysis of the resources and process of pathway devel-
opment identified that several services linked to specific 
pathways had not yet been configured. This meant that 
delivery was slower for some pathways, leading to addi-
tional time spent by clinical editors and subject matter 
experts, and potential loss of return on investment. Other 
studies have attempted to quantify the costs of clinician 
input into service development.37 The emerging role 
of clinicians’ involvement as a potential transformer of 
services through the development of online care pathways 
requires further consideration in terms of the require-
ments and resources allocated.15
Users reported that HealthPathways was an important 
new resource for decision-making and referrals enabling 
them to carry out their role more effectively. Shared 
decision-making with patients is an important local and 
national policy driver, which can be supported by the 
use of online care pathways and resources.38 39 Under-
standing the decision-making process through analysis 
of non-compliance or variance from agreed pathways was 
not within the scope of this study as data about referrals 
linked to agreed pathways were unavailable; however, 
several patient stories were cited with positive outcomes 
for patients. The influence of HealthPathways on shared 
decision-making requires further study.
Other researchers have found a reluctance to use 
guidelines and care pathways because there is often a 
perception that they are perceived to reduce professional 
judgement, personal focus on the patient and job satis-
faction.6 40 Others have found endorsement for pathways, 
but subsequently little evidence of actual use.10 11 This 
was not the case in this study, where our early data indi-
cated increasing use of HealthPathways. In future, users 
will have individual rather than site logins, enabling data 
to be gathered to correlate between users, referrals and 
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outcomes. Other researchers have focused in more depth 
on the need for audit and analysis of variance in use of 
agreed pathways9 37 38; however, quantitative data of the 
kind collected in this study could provide an analysis of 
non-compliance with, or variance from, pathways and 
could also strengthen future studies and service develop-
ment.26 41 42 Ideally variance should be captured automat-
ically as part of recording use.
ConClusIon
This study has provided early findings in relation to the 
implementation of online care pathways across health 
and social care. The configurations provide a framework 
for considerations to be made for future implementa-
tions sites. We found most users engaged with the prin-
ciple of online care pathways as a tool in their day-to-day 
work, seeing the benefit for their patients and their local 
system. System leaders were seeing sustained uptake and 
engagement, with access now also being provided for a 
wider group of health professionals including nurses.
As other sites in the UK begin to implement Health-
Pathways, there will be an opportunity for further research 
into online care pathways across the health and social 
care system, and to explore how context may affect imple-
mentation. New sites should ensure data collection and 
monitoring systems focus on outcomes (patient and care 
system) to establish return on investment and support 
future research in this area. Management of clinicians’ 
expectations during the introductory phase could address 
tensions found between the ideal vision of HealthPath-
ways voiced by system leaders and uncertainties voiced by 
users deriving from early practical experiences.
In New Zealand, a patient-accessible view of Health-
Pathways has been developed to support a partnership 
approach to care and treatment, with patients being able 
to view a pathway before they consult a relevant health 
professional or see their GP. In this study, initial patient 
stories recounted by clinicians provided useful insights 
into patient outcomes; however, further involvement 
of patients in research into care pathways may provide 
different perspectives and contribute to care pathway and 
service development.
Acknowledgements The authors thank the participants from general practices 
in South Tyneside, South Tyneside NHS Foundation Trust, South Tyneside Clinical 
Commissioning Group, North of England Commissioning Support in particular 
the support of Shona Haining and Mark Girvan, South Tyneside District Council, 
HealthNet (link group to voluntary care organisations), Streamliners NZ.
Contributors JA was principal investigator, carried out some of the interviews and 
final analysis and was responsible for leading the writing of the manuscript. ZS 
gathered interview and focus group data, provided initial analysis of themes using 
Nvivo and a draft of initial findings. IG carried out manual analysis of transcripts 
during final stages of the project and contributed to the writing of the manuscript. 
JL assisted with the analysis and contributed to the writing of the manuscript.
Funding Funding for this research was provided by North of England 
Commissioning Support (NECS) and Streamliners (supplier of HealthPathways) 
https:// streamliners. co. nz/ HealthPathways. aspx. NECS provided representatives for 
the research project steering group.
Disclaimer The views expressed in this article are those of the research team and 
not an official position of the institution or funder.
Competing interests IG is married to a member of the executive team in South 
Tyneside Clinical Commissioning Group.
Patient consent for publication Not required.
ethics approval Sunderland Research Ethics Committee and Health Research 
Authority (HRA). 
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Dataset available from the University of Sunderland 
respository SURE; access to data available on request.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. NHS. NHS England five year forward view. https://www. england. nhs. 
uk/ wp- content/ uploads/ 2014/ 10/ 5yfv- web. pdf (accessed 14 Feb 
2018).
 2. NHS. NHS England workforce. https://www. england. nhs. uk/ 
integrated- care- pioneers/ resources/ workforce/ (accessed 14 Feb 
2018).
 3. Health Education England. Building a digital ready workforce. 
2017 https:// hee. nhs. uk/ our- work/ building- digital- ready- workforce 
(accessed 4 Jun 2018).
 4. Blaser R, Schnabel M, Biber C, et al. Improving pathway compliance 
and clinician performance by using information technology. Int J Med 
Inform 2007;76:151–6.
 5. Brennan N, Mattick K, Ellis T. The Map of Medicine: a review 
of evidence for its impact on healthcare. Health Info Libr J 
2011;28:93–100.
 6. Rooney E. Developing care pathways--lessons from the Steele 
Review implementation in England. Gerodontology 2014;31:52–9.
 7. Rotter T, Kinsman L, James E, et al. Clinical pathways: effects on 
professional practice, patient outcomes, length of stay and hospital 
costs. Cochrane Database Syst Rev 2010;3:CD006632.
 8. NHS. Next steps on the NHS five year forward view. https://www. 
england. nhs. uk/ wp- content/ uploads/ 2017/ 03/ NEXT- STEPS- ON- 
THE- NHS- FIVE- YEAR- FORWARD- VIEW. pdf (accessed 14 Feb 2018).
 9. Atwal A, Caldwell K. Do multidisciplinary integrated care pathways 
improve interprofessional collaboration? Scand J Caring Sci 
2002;16:360–7.
 10.  CPA- Rapid- Review- Effectiveness- of- care- pathways. pdf. http://www. 
cpa. org. uk/ information/ reviews/ CPA- Rapid- Review- Effectiveness- of- 
care- pathways. pdf (accessed 18 Feb 2018).
 11. Hindle D, Yazbeck AM. Clinical pathways in 17 European Union 
countries: a purposive survey. Aust Health Rev 2005;29:94.
 12. Horrocks S, Anderson E, Salisbury C. Systematic review of whether 
nurse practitioners working in primary care can provide equivalent 
care to doctors. BMJ 2002;324:819–23.
 13. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical 
practice: a systematic review of rigorous evaluations. The Lancet 
1993;342:1317–22.
 14. Charles A. Developing accountable care systems. https://www. 
kingsfund. org. uk/ publications/ developing- accountable- care- 
systems.
 15. Timmins N, Ham C. The quest for integrated care in New Zealand. 
https://www. kingsfund. org. uk/ sites/ default/ files/ field/ field_ 
publication_ file/ quest- integrated- care- new- zealand- timmins- ham- 
sept13. pdf (accessed 14 Feb 2018).
 16. HealthPathways Community. HP Community. https://www. heal thpa 
thwa ysco mmunity. org/ (accessed 14 Feb 2018).
 17. Alison Boughey Consulting HealthPathways: An evaluation of its 
implementation in five Australian Medicare Locals. http://www. alis 
onbo ughe ycon sulting. com. au/ wordpress/ wp- content/ uploads/ 2013/ 
01/ Alison- Boughey- Consulting- AML- Alliance- HealthPathways- 
evaluation- final- report. pdf (accessed 14 Feb 2018).
 18. McGeoch G, McGeoch P, Shand B. Is HealthPathways effective? An 
online survey of hospital clinicians, general practitioners and practice 
nurses. N Z Med J 2015;128:1408.
 19. England NHS. Integrated care pioneers. https://www. england. nhs. uk/ 
integrated- care- pioneers/ (accessed 14 Feb 2018).
 o
n
 31 Decem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022991 on 31 December 2018. Downloaded from 
11Akehurst J, et al. BMJ Open 2018;8:e022991. doi:10.1136/bmjopen-2018-022991
Open access
 20. Pawson R, Tilley N. Realistic Evaluation. London: Sage.
 21. Pawson R, Greenhalgh T, Harvey G, et al. Realist review--a 
new method of systematic review designed for complex policy 
interventions. J Health Serv Res Policy 2005;10:21–34.
 22. Moore GF, Audrey S, Barker M, et al. Process evaluation of 
complex interventions: medical research council guidance. BMJ 
2015;350:h1258.
 23. Rycroft-Malone J, Fontenla M, Bick D, et al. A realistic evaluation: the 
case of protocol-based care. Implement Sci 2010;5:38.
 24. Ogrinc G, Davies L, Goodman D, et al. SQUIRE 2.0 (Standards for 
QUality Improvement Reporting Excellence): revised publication 
guidelines from a detailed consensus process. Am J Med Qual 
2015;30:543–9.
 25. Røsstad T, Garåsen H, Steinsbekk A, et al. Implementing a care 
pathway for elderly patients, a comparative qualitative process 
evaluation in primary care. BMC Health Serv Res 2015;15:86.
 26. Deneckere S, Euwema M, Van Herck P, et al. Care pathways lead 
to better teamwork: results of a systematic review. Soc Sci Med 
2012;75:264–8. 1.
 27. Greenhalgh T, Robert G, Macfarlane F, et al. Diffusion of innovations 
in service organizations: systematic review and recommendations. 
Milbank Q 2004;82:581–629.
 28. Brown BB, Patel C, McInnes E, et al. The effectiveness of clinical 
networks in improving quality of care and patient outcomes: a 
systematic review of quantitative and qualitative studies. BMC Health 
Serv Res 2016;16:360.
 29. NHS. Developing people improving care. https:// improvement. nhs. 
uk/ documents/ 542/ Developing_ People- Improving_ Care- 010216. pdf 
(accessed 6 Jun 2018).
 30. West M, Eckert R, Steward K, et al. Developing collective leadership 
for health care. 36.
 31. Evans-Lacko S, Jarrett M, McCrone P, et al. Facilitators and barriers 
to implementing clinical care pathways. BMC Health Serv Res 
2010;10:182.
 32. Robinson S, Varhol R, Bell C, et al. HealthPathways: creating a 
pathway for health systems reform. Aust Health Rev 2015;39:9–11.
 33. Mansfield SJ, Quirk F, von Treuer K, et al. On the right path? 
Exploring the experiences and opinions of clinicians involved in 
developing and implementing HealthPathways Barwon. Aust Health 
Rev 2016;40:129–35.
 34. Greenhalgh T, Wong G, Jagosh J, et al. Protocol--the RAMESES 
II study: developing guidance and reporting standards for realist 
evaluation. BMJ Open 2015;5:e008567.
 35. Gagliardi AR, Marshall C, Huckson S, et al. Developing a checklist 
for guideline implementation planning: review and synthesis of 
guideline development and implementation advice. Implement Sci 
2015;10:19.
 36. Lacouture A, Breton E, Guichard A, et al. The concept of 
mechanism from a realist approach: a scoping review to facilitate its 
operationalization in public health program evaluation. Implement Sci 
2015;10:153.
 37. McLaughlin N, Burke MA, Setlur NP, et al. Time-driven activity-based 
costing: a driver for provider engagement in costing activities and 
redesign initiatives. Neurosurg Focus 2014;37:E3.
 38. NHS. RightCare shared decision making programme. https://www. 
england. nhs. uk/ rightcare/ shared- decision- making/ (accessed 4 Jun 
2018).
 39. Coulter A, Edwards A, Elwyn G, et al. Implementing shared 
decision making in the UK. Z Evid Fortbild Qual Gesundhwes 
2011;105:300–4.
 40. Woolf SH, Grol R, Hutchinson A, et al. limitations, and harms of 
clinical guidelines. BMJ 1999;318:527–30.
 41. Croucher M. An evaluation of the quality of integrated care pathway 
development in the UK national health service. Journal of integrated 
Care Pathways 2005;9:6–12.
 42. Campbell H, Hotchkiss R, Bradshaw N, et al. Integrated care 
pathways. BMJ 1998;316:133–7.
 o
n
 31 Decem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022991 on 31 December 2018. Downloaded from 
